Annual CFO
$1.40 B
+$707.96 M+102.11%
30 June 2024
Summary:
ResMed annual cash flow from operations is currently $1.40 billion, with the most recent change of +$707.96 million (+102.11%) on 30 June 2024. During the last 3 years, it has risen by +$664.54 million (+90.20%). RMD annual CFO is now at all-time high.RMD Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$325.54 M
-$114.58 M-26.03%
30 September 2024
Summary:
ResMed quarterly cash flow from operations is currently $325.54 million, with the most recent change of -$114.58 million (-26.03%) on 30 September 2024. Over the past year, it has increased by +$39.26 million (+13.71%). RMD quarterly CFO is now -26.03% below its all-time high of $440.11 million, reached on 30 June 2024.RMD Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$1.44 B
+$39.26 M+2.80%
30 September 2024
Summary:
ResMed TTM cash flow from operations is currently $1.44 billion, with the most recent change of +$39.26 million (+2.80%) on 30 September 2024. Over the past year, it has increased by +$505.60 million (+54.08%). RMD TTM CFO is now at all-time high.RMD TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RMD Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +102.1% | +13.7% | +54.1% |
| 3 y3 years | +90.2% | +595.8% | +173.3% |
| 5 y5 years | +205.3% | +100.5% | +151.3% |
RMD Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +299.1% | -26.0% | +595.8% | at high | +310.2% |
| 5 y | 5 years | at high | +299.1% | -26.0% | +595.8% | at high | +310.2% |
| alltime | all time | at high | >+9999.0% | -26.0% | +595.8% | at high | >+9999.0% |
ResMed Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $325.54 M(-26.0%) | $1.44 B(+2.8%) |
| June 2024 | $1.40 B(+102.1%) | $440.11 M(+9.5%) | $1.40 B(+16.9%) |
| Mar 2024 | - | $402.03 M(+47.4%) | $1.20 B(+11.1%) |
| Dec 2023 | - | $272.83 M(-4.7%) | $1.08 B(+15.4%) |
| Sept 2023 | - | $286.28 M(+20.6%) | $934.92 M(+34.9%) |
| June 2023 | $693.30 M(+97.4%) | $237.44 M(-16.0%) | $693.30 M(+29.5%) |
| Mar 2023 | - | $282.56 M(+119.7%) | $535.35 M(+44.6%) |
| Dec 2022 | - | $128.64 M(+188.0%) | $370.22 M(-19.8%) |
| Sept 2022 | - | $44.66 M(-43.8%) | $461.47 M(+31.4%) |
| June 2022 | $351.15 M(-52.3%) | $79.49 M(-32.3%) | $351.15 M(-29.5%) |
| Mar 2022 | - | $117.44 M(-46.6%) | $498.19 M(-13.7%) |
| Dec 2021 | - | $219.88 M(-434.9%) | $577.02 M(+9.5%) |
| Sept 2021 | - | -$65.66 M(-129.0%) | $527.06 M(-28.5%) |
| June 2021 | $736.72 M(-8.2%) | $226.53 M(+15.4%) | $736.72 M(-12.3%) |
| Mar 2021 | - | $196.28 M(+15.5%) | $840.46 M(-4.9%) |
| Dec 2020 | - | $169.92 M(+18.0%) | $883.88 M(+12.8%) |
| Sept 2020 | - | $144.00 M(-56.4%) | $783.89 M(-2.3%) |
| June 2020 | $802.25 M(+74.8%) | $330.26 M(+37.8%) | $802.25 M(+30.7%) |
| Mar 2020 | - | $239.69 M(+242.8%) | $613.81 M(+19.5%) |
| Dec 2019 | - | $69.93 M(-56.9%) | $513.76 M(-10.4%) |
| Sept 2019 | - | $162.36 M(+14.5%) | $573.29 M(+24.9%) |
| June 2019 | $459.05 M(-9.1%) | $141.82 M(+1.6%) | $459.05 M(+2.8%) |
| Mar 2019 | - | $139.65 M(+7.9%) | $446.65 M(-2.1%) |
| Dec 2018 | - | $129.47 M(+169.1%) | $456.08 M(-0.7%) |
| Sept 2018 | - | $48.12 M(-62.8%) | $459.16 M(-9.1%) |
| June 2018 | $505.03 M(+22.0%) | $129.42 M(-13.2%) | $505.03 M(-2.1%) |
| Mar 2018 | - | $149.08 M(+12.5%) | $515.92 M(+18.8%) |
| Dec 2017 | - | $132.55 M(+41.0%) | $434.44 M(+3.0%) |
| Sept 2017 | - | $93.98 M(-33.0%) | $421.79 M(+1.9%) |
| June 2017 | $414.05 M(-24.4%) | $140.31 M(+107.6%) | $414.05 M(-0.6%) |
| Mar 2017 | - | $67.60 M(-43.6%) | $416.70 M(-12.1%) |
| Dec 2016 | - | $119.90 M(+39.0%) | $473.85 M(-7.0%) |
| Sept 2016 | - | $86.24 M(-39.7%) | $509.57 M(-7.0%) |
| June 2016 | $547.93 M(+43.0%) | $142.96 M(+14.6%) | $547.93 M(+8.6%) |
| Mar 2016 | - | $124.75 M(-19.8%) | $504.67 M(+7.2%) |
| Dec 2015 | - | $155.61 M(+24.9%) | $470.86 M(+11.8%) |
| Sept 2015 | - | $124.61 M(+25.0%) | $421.25 M(+9.9%) |
| June 2015 | $383.18 M(-2.1%) | $99.70 M(+9.6%) | $383.18 M(-4.0%) |
| Mar 2015 | - | $90.94 M(-14.2%) | $399.06 M(-2.5%) |
| Dec 2014 | - | $106.00 M(+22.5%) | $409.22 M(+5.6%) |
| Sept 2014 | - | $86.54 M(-25.1%) | $387.38 M(-1.0%) |
| June 2014 | $391.27 M(-2.9%) | $115.58 M(+14.3%) | $391.27 M(-2.1%) |
| Mar 2014 | - | $101.09 M(+20.1%) | $399.61 M(-1.5%) |
| Dec 2013 | - | $84.17 M(-6.9%) | $405.51 M(-2.3%) |
| Sept 2013 | - | $90.42 M(-27.0%) | $414.99 M(+3.0%) |
| June 2013 | $402.82 M(+5.1%) | $123.92 M(+15.8%) | $402.82 M(+7.2%) |
| Mar 2013 | - | $107.00 M(+14.3%) | $375.88 M(+5.9%) |
| Dec 2012 | - | $93.65 M(+19.7%) | $354.90 M(-4.6%) |
| Sept 2012 | - | $78.25 M(-19.3%) | $371.89 M(-2.9%) |
| June 2012 | $383.16 M(+35.3%) | $96.98 M(+12.7%) | $383.16 M(+6.3%) |
| Mar 2012 | - | $86.03 M(-22.2%) | $360.51 M(+1.3%) |
| Dec 2011 | - | $110.63 M(+23.6%) | $355.89 M(+13.5%) |
| Sept 2011 | - | $89.52 M(+20.4%) | $313.57 M(+10.7%) |
| June 2011 | $283.19 M(+50.5%) | $74.33 M(-8.7%) | $283.19 M(+5.7%) |
| Mar 2011 | - | $81.41 M(+19.2%) | $267.82 M(+11.6%) |
| Dec 2010 | - | $68.31 M(+15.5%) | $239.96 M(+31.0%) |
| Sept 2010 | - | $59.14 M(+0.3%) | $183.22 M(-2.7%) |
| June 2010 | $188.21 M | $58.96 M(+10.1%) | $188.21 M(-5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $53.54 M(+362.8%) | $199.48 M(+4.9%) |
| Dec 2009 | - | $11.57 M(-82.0%) | $190.19 M(-19.1%) |
| Sept 2009 | - | $64.14 M(-8.7%) | $235.11 M(-1.6%) |
| June 2009 | $238.88 M(+73.3%) | $70.23 M(+58.7%) | $238.88 M(+5.9%) |
| Mar 2009 | - | $44.25 M(-21.7%) | $225.50 M(+4.8%) |
| Dec 2008 | - | $56.49 M(-16.8%) | $215.19 M(+21.2%) |
| Sept 2008 | - | $67.91 M(+19.4%) | $177.61 M(+28.9%) |
| June 2008 | $137.84 M(+51.3%) | $56.85 M(+67.5%) | $137.84 M(+27.5%) |
| Mar 2008 | - | $33.93 M(+79.3%) | $108.09 M(+14.4%) |
| Dec 2007 | - | $18.92 M(-32.7%) | $94.46 M(+1.5%) |
| Sept 2007 | - | $28.13 M(+3.8%) | $93.10 M(+2.2%) |
| June 2007 | $91.11 M(-8.0%) | $27.11 M(+33.5%) | $91.11 M(-8.3%) |
| Mar 2007 | - | $20.30 M(+15.6%) | $99.31 M(-11.2%) |
| Dec 2006 | - | $17.56 M(-32.8%) | $111.84 M(+2.4%) |
| Sept 2006 | - | $26.13 M(-26.0%) | $109.22 M(+10.3%) |
| June 2006 | $99.03 M(+39.3%) | $35.31 M(+7.6%) | $99.03 M(+16.5%) |
| Mar 2006 | - | $32.83 M(+119.6%) | $85.00 M(+34.8%) |
| Dec 2005 | - | $14.95 M(-6.2%) | $63.04 M(-10.5%) |
| Sept 2005 | - | $15.94 M(-25.1%) | $70.40 M(-1.0%) |
| June 2005 | $71.08 M(-7.1%) | $21.28 M(+95.9%) | $71.08 M(-2.8%) |
| Mar 2005 | - | $10.87 M(-51.3%) | $73.13 M(-18.3%) |
| Dec 2004 | - | $22.31 M(+34.3%) | $89.47 M(+11.0%) |
| Sept 2004 | - | $16.62 M(-28.8%) | $80.59 M(+5.3%) |
| June 2004 | $76.54 M(+29.1%) | $23.33 M(-14.3%) | $76.54 M(+1.6%) |
| Mar 2004 | - | $27.21 M(+102.6%) | $75.36 M(+15.7%) |
| Dec 2003 | - | $13.43 M(+6.9%) | $65.11 M(+2.1%) |
| Sept 2003 | - | $12.57 M(-43.3%) | $63.80 M(+7.6%) |
| June 2003 | $59.28 M(+66.3%) | $22.15 M(+30.5%) | $59.28 M(+30.0%) |
| Mar 2003 | - | $16.97 M(+40.0%) | $45.59 M(+13.4%) |
| Dec 2002 | - | $12.12 M(+50.5%) | $40.19 M(+23.8%) |
| Sept 2002 | - | $8.05 M(-4.8%) | $32.46 M(-8.9%) |
| June 2002 | $35.64 M(+20.7%) | $8.46 M(-26.9%) | $35.64 M(-3.9%) |
| Mar 2002 | - | $11.57 M(+163.4%) | $37.07 M(+12.0%) |
| Dec 2001 | - | $4.39 M(-60.9%) | $33.10 M(-3.9%) |
| Sept 2001 | - | $11.23 M(+13.6%) | $34.46 M(+16.7%) |
| June 2001 | $29.52 M(+45.6%) | $9.89 M(+30.1%) | $29.52 M(+10.3%) |
| Mar 2001 | - | $7.60 M(+32.3%) | $26.77 M(+5.8%) |
| Dec 2000 | - | $5.75 M(-8.7%) | $25.31 M(+11.2%) |
| Sept 2000 | - | $6.29 M(-11.9%) | $22.77 M(+12.3%) |
| June 2000 | $20.27 M(+11.4%) | $7.14 M(+16.3%) | $20.27 M(+19.0%) |
| Mar 2000 | - | $6.14 M(+91.8%) | $17.04 M(+6.5%) |
| Dec 1999 | - | $3.20 M(-15.8%) | $16.00 M(-9.1%) |
| Sept 1999 | - | $3.80 M(-2.6%) | $17.60 M(-3.3%) |
| June 1999 | $18.20 M(+167.6%) | $3.90 M(-23.5%) | $18.20 M(+0.6%) |
| Mar 1999 | - | $5.10 M(+6.3%) | $18.10 M(+23.1%) |
| Dec 1998 | - | $4.80 M(+9.1%) | $14.70 M(+51.5%) |
| Sept 1998 | - | $4.40 M(+15.8%) | $9.70 M(+42.6%) |
| June 1998 | $6.80 M(-28.4%) | $3.80 M(+123.5%) | $6.80 M(+17.2%) |
| Mar 1998 | - | $1.70 M(-950.0%) | $5.80 M(-6.5%) |
| Dec 1997 | - | -$200.00 K(-113.3%) | $6.20 M(-32.6%) |
| Sept 1997 | - | $1.50 M(-46.4%) | $9.20 M(-3.2%) |
| June 1997 | $9.50 M(+171.4%) | $2.80 M(+33.3%) | $9.50 M(+41.8%) |
| Mar 1997 | - | $2.10 M(-25.0%) | $6.70 M(+45.7%) |
| Dec 1996 | - | $2.80 M(+55.6%) | $4.60 M(+155.6%) |
| Sept 1996 | - | $1.80 M | $1.80 M |
| June 1996 | $3.50 M(+400.0%) | - | - |
| June 1995 | $700.00 K(-56.3%) | - | - |
| June 1994 | $1.60 M(+60.0%) | - | - |
| June 1993 | $1.00 M | - | - |
FAQ
- What is ResMed annual cash flow from operations?
- What is the all time high annual CFO for ResMed?
- What is ResMed annual CFO year-on-year change?
- What is ResMed quarterly cash flow from operations?
- What is the all time high quarterly CFO for ResMed?
- What is ResMed quarterly CFO year-on-year change?
- What is ResMed TTM cash flow from operations?
- What is the all time high TTM CFO for ResMed?
- What is ResMed TTM CFO year-on-year change?
What is ResMed annual cash flow from operations?
The current annual CFO of RMD is $1.40 B
What is the all time high annual CFO for ResMed?
ResMed all-time high annual cash flow from operations is $1.40 B
What is ResMed annual CFO year-on-year change?
Over the past year, RMD annual cash flow from operations has changed by +$707.96 M (+102.11%)
What is ResMed quarterly cash flow from operations?
The current quarterly CFO of RMD is $325.54 M
What is the all time high quarterly CFO for ResMed?
ResMed all-time high quarterly cash flow from operations is $440.11 M
What is ResMed quarterly CFO year-on-year change?
Over the past year, RMD quarterly cash flow from operations has changed by +$39.26 M (+13.71%)
What is ResMed TTM cash flow from operations?
The current TTM CFO of RMD is $1.44 B
What is the all time high TTM CFO for ResMed?
ResMed all-time high TTM cash flow from operations is $1.44 B
What is ResMed TTM CFO year-on-year change?
Over the past year, RMD TTM cash flow from operations has changed by +$505.60 M (+54.08%)